Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AusDiagnostics' multiplexed molecular diagnostic products are commercially available and widely used in clinical laboratories and hospitals globally. Their MT-PCR platform enables simultaneous detection of up to dozens of pathogens or resistance genes from a single sample. The company has expanded its product suite through ongoing R&D and partnerships such as with OrthoDx for orthopaedic infection diagnostics. Their products have been CE marked in the EU for key infectious disease panels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AusDiagnostics.